-       Report 
- March 2022
-  553 Pages 
- Global 
   From       €2450EUR$2,934USD£2,231GBP 
          -       Report 
- January 2022
-  139 Pages 
- Global 
   From       €3041EUR$3,400USD£2,675GBP 
          -       Training 
- October 2021
-  1 Day 
- Latin America 
   From       €1162EUR$1,299USD£1,022GBP 
          -       Report 
- July 2021
-  128 Pages 
- Global 
   From       €3578EUR$4,000USD£3,147GBP 
          -       Report 
- June 2021
-  675 Pages 
- Global 
   From       €3801EUR$4,250USD£3,344GBP 
           -       Report 
- April 2021
-  9 Pages 
- Global 
        €1565EUR$1,750USD£1,377GBP 
          -       Report 
- March 2021
-  137 Pages 
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
            -       Report 
- February 2021
-  80 Pages 
- India 
   From       €852EUR$952USD£749GBP 
      €1064EUR$1,190USD£936GBP 
          -       Report 
- January 2021
-  109 Pages 
- Global 
        €3990EUR$4,779USD£3,633GBP 
          -       Report 
- December 2020
-  20 Pages 
- United States 
        €1386EUR$1,550USD£1,220GBP 
          -       Report 
- October 2020
-  57 Pages 
- Global 
             -       Report 
- September 2020
-  700 Pages 
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
            -       Report 
- April 2020
-  165 Pages 
- Global 
   From       €995EUR$1,112USD£875GBP 
      €1243EUR$1,390USD£1,094GBP 
          -       Report 
- January 2020
-  156 Pages 
- Japan 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Drug Pipelines 
- January 2020
-  1500 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
          -       Report 
- March 2019
-  80 Pages 
- Global 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Clinical Trials 
- September 2018
-  700 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
          -       Report 
- July 2018
-  224 Pages 
- Global 
   From       €1610EUR$1,800USD£1,416GBP 
          -       Drug Pipelines 
- January 2018
-  16 Pages 
- Global 
   From       €8945EUR$10,000USD£7,868GBP 
          -       Training 
-  90 Minutes 
- Global 
          
       The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically    more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less   Read more